semaglutide original use FDA Approval vs Compounded Alternatives In the original clinical trials

7.3.3 Safety and specificity concerns Long-term safety assessment remains paramount, particularly regarding the theoretical risk of impairing tumor surveillance by chronically inhibiting a controlled cell death pathway, potential off-target effects of RNA-based therapies, and the challenge of achieving cell-type specificity without affecting essential ferroptosis functions in other tissues

The results showed inconsistencies in what was in each sample

Hypothyroid symptoms include unexplained fatigue, cold intolerance, constipation, dry skin, or unintended weight gain despite continued semaglutide use

K., Shenouda, S

Injectable delivery bypasses these variables entirely